| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 06/07/2020 | 15:16 | InvestorsHub NewsWire | The Rapid Rise of Alternet Systems, Inc. (OTCMKTS: ALYI) | USOTC:DECN | Decision Diagnostics Corporation (CE) |
| 04/03/2020 | 16:15 | InvestorsHub NewsWire | DECN Fills in the Gaps, Adds to Knowledge Base for its GenViro Coronavirus (Covid19) Multi-Dimensional Diagnostic Methodology | USOTC:DECN | Decision Diagnostics Corporation (CE) |
| 09/05/2019 | 15:55 | InvestorsHub NewsWire | DECN SETS PLAN TO MAKE UPCOMING PATENT APPEAL HEARING AND MEDIATION WITH JOHNSON & JOHNSON A FOUNDATION FOR SUBSTANTIAL RECOV... | USOTC:DECN | Decision Diagnostics Corporation (CE) |
| 04/04/2019 | 16:00 | InvestorsHub NewsWire | DECN HAILS COMPLETION OF ITS GENULTIMATE! TBG PANACEA SYSTEM, 3RD PARTY TESTING TO BEGIN IN 7 DAYS, CLINICAL TRIALS IN MAY | USOTC:DECN | Decision Diagnostics Corporation (CE) |
| 18/03/2019 | 21:35 | Edgar (US Regulatory) | Withdrawal of Offering Statement Under Regulation a (1-a-w) | USOTC:DECN | Decision Diagnostics Corporation (CE) |
| 25/02/2019 | 21:34 | Edgar (US Regulatory) | Amended Registration a Offering Under the Securities Act of 1933 (1-a/a) | USOTC:DECN | Decision Diagnostics Corporation (CE) |
| 30/01/2019 | 16:00 | InvestorsHub NewsWire | DECN SUBSIDIARY RECEIVES 510K SUBMISSION AND "K" NUMBERS FROM FDA CDRH FOR ITS GENCHOICE! TEST STRIP AT THE CLOSE OF THE | USOTC:DECN | Decision Diagnostics Corporation (CE) |
| 17/01/2019 | 15:55 | InvestorsHub NewsWire | DECN DISCUSSES ITS GENULTIMATE! TBG SYSTEM, OFFERING ELITE PERFORMANCE AND PREMIER UPGRADE PATH FOR 4+ MILLION LIFESCAN USERS | USOTC:DECN | Decision Diagnostics Corporation (CE) |
| 19/12/2018 | 16:03 | InvestorsHub NewsWire | DECN SUBSIDIARIES APPEAL NEVADA DISTRICT COURT RULING TO U.S. COURT OF APPEALS FOR THE FEDERAL CIRCUIT (the patent court) | USOTC:DECN | Decision Diagnostics Corporation (CE) |
| 17/12/2018 | 15:55 | InvestorsHub NewsWire | DECN ENGAGES SECOND KOREAN MANUFACTURING PARTNER TO RAISE ITS FACTORY CAPACITY TWO MILLION BOXES OF "GEN" TEST STRIPS ANNUALLY | USOTC:DECN | Decision Diagnostics Corporation (CE) |
| 11/12/2018 | 16:00 | InvestorsHub NewsWire | DECN RELEASES ITS STRATEGIC IP AND PRODUCT DEVELOPMENT INTRODUCTION PLAN WITH A SUMMARY OF 2018 ACHIEVEMENTS & 2019 EXPECTATI... | USOTC:DECN | Decision Diagnostics Corporation (CE) |
| 04/12/2018 | 16:00 | InvestorsHub NewsWire | DECN RECEIVES CLINICAL TRIALS REPORT, ANTICIPATES FILING ITS FDA 510K APPLICATION FOR ITS GENCHOICE! TEST STRIP ON 12/21/2018 | USOTC:DECN | Decision Diagnostics Corporation (CE) |
| 27/11/2018 | 15:50 | InvestorsHub NewsWire | DECN CEO KEITH M. BERMAN IS INTERVIEWED BY PRESTIGIOUS WALL STREET REPORTER WHO DESCRIBE COMPANY & PRODUCTS AS "GAME CHANGER" | USOTC:DECN | Decision Diagnostics Corporation (CE) |
| 06/11/2018 | 15:55 | InvestorsHub NewsWire | DECN RECEIVES COMPLETED CLINICAL TRIAL DATA, CHARTS AND SPREADSHEETS ESSENTIAL FOR ITS IMMINENT GENCHOICE! TEST STRIP | USOTC:DECN | Decision Diagnostics Corporation (CE) |
| 30/10/2018 | 14:33 | InvestorsHub NewsWire | DECN SET TO APPEAL UNFAIR RULING IN COURT'S TERMINATION OF THE DECN CASE AGAINST INDUSTRY GIANT JOHNSON & JOHNSON | USOTC:DECN | Decision Diagnostics Corporation (CE) |
| 29/10/2018 | 15:15 | InvestorsHub NewsWire | DECN TO COMMENT AND PROVIDE ATTACK PLAN AFTER RECENT COURT RULING | USOTC:DECN | Decision Diagnostics Corporation (CE) |
| 13/09/2018 | 16:00 | InvestorsHub NewsWire | DECN BOARD OF DIRECTORS IN FINAL REVIEW OF PRELIMINARY FINANCING AGREEMENT FOR $4.75 MILLION INVESTMENT | USOTC:DECN | Decision Diagnostics Corporation (CE) |
| 06/09/2018 | 16:00 | InvestorsHub NewsWire | DECN ANNOUNCES MAJOR STEP AHEAD WITH OFFERING STATEMENT | USOTC:DECN | Decision Diagnostics Corporation (CE) |
| 01/08/2018 | 14:06 | Edgar (US Regulatory) | Registration a Offering Under the Securities Act of 1933 (1-a) | USOTC:DECN | Decision Diagnostics Corporation (CE) |
| 18/04/2018 | 15:51 | InvestorsHub NewsWire | Decision Diagnostics (DECN) Contemplates Additional Legal Actions Against Longtime Adversary Johnson & Johnson (JNJ) | USOTC:DECN | Decision Diagnostics Corporation (CE) |
| 27/03/2018 | 21:05 | InvestorsHub NewsWire | DECISION DIAGNOSTICS DISCUSSES CULMINATION OF PATENT CASE AGAINST J&J BASED ON THE FEDERAL DOCTRINE OF EQUIVALENTS | USOTC:DECN | Decision Diagnostics Corporation (CE) |
| 21/03/2018 | 14:40 | InvestorsHub NewsWire | DECISION DIAGNOSTICS' PANACEA GENPRECIS! PRODUCT MOVES INTO PRE-PRODUCTION, 1ST ROUND CLINICAL TRIALS TO BEGIN IN THE ~30 DAYS | USOTC:DECN | Decision Diagnostics Corporation (CE) |
| 13/03/2018 | 14:50 | InvestorsHub NewsWire | Decision Diagnostics' Fundamental Genchoice! Test Strip Moves into Clinical Trials in Advance of 510K Filing with FDA | USOTC:DECN | Decision Diagnostics Corporation (CE) |
| 03/01/2018 | 15:55 | InvestorsHub NewsWire | DECN ANNOUNCES 2018 BUSINESS FOCUS -- NEW PRODUCTS, CONCLUSION TO J&J LITIGATION & NEW ADDITION OF HYBRID PRIVATE LABEL MODEL | USOTC:DECN | Decision Diagnostics Corporation (CE) |
| 20/12/2017 | 16:15 | InvestorsHub NewsWire | DECISION DIAGNOSTICS PROVIDES ADDITIONAL COMMENTARY ABOUT ITS NEW GENACCORD!™, DIABETIC TEST STRIP | USOTC:DECN | Decision Diagnostics Corporation (CE) |
| 14/12/2017 | 16:00 | InvestorsHub NewsWire | DECN ANNOUNCES IT'S NEW GENACCORD!™, DIABETIC TEST STRIP WITH FIRST USE OF ITS GENPRECIS!™ FULL SPREAD ELECTRODE ... | USOTC:DECN | Decision Diagnostics Corporation (CE) |
| 01/11/2017 | 15:15 | InvestorsHub NewsWire | DECISION DIAGNOSTICS CORP. (DECN) OFFERS UPDATE ON LEGAL PROCEEDINGS, OUTCOMES, HISTORY & SYNOPSIS ON ITS STRATEGIC SUIT VS. ... | USOTC:DECN | Decision Diagnostics Corporation (CE) |
| 18/10/2017 | 16:10 | InvestorsHub NewsWire | DECISION DIAGNOSTICS CORP FURTHER DISCUSSES ITS PANACEA GENPRECIS!™ PRODUCT | USOTC:DECN | Decision Diagnostics Corporation (CE) |
| 13/10/2017 | 16:00 | InvestorsHub NewsWire | DECN Announces Completion of Feasibility Testing for The Inspired Genpresis! Precision Diabetes Testing Meter and Test Strip | USOTC:DECN | Decision Diagnostics Corporation (CE) |
| 12/10/2017 | 16:00 | InvestorsHub NewsWire | Decision Diagnostics Announces the Completion of Development and the Onset of Clinical Trials for Its Fundamental Genchoice!(... | USOTC:DECN | Decision Diagnostics Corporation (CE) |